296 related articles for article (PubMed ID: 24316265)
1. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
[TBL] [Abstract][Full Text] [Related]
2. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery.
Ren X; Svirskis D; Alany RG; Zargar-Shoshtari S; Wu Z
Int J Pharm; 2012 Jul; 431(1-2):130-7. PubMed ID: 22548845
[TBL] [Abstract][Full Text] [Related]
3. In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Li Y; Angelova A; Liu J; Garamus VM; Li N; Drechsler M; Gong Y; Zou A
Colloids Surf B Biointerfaces; 2019 Jan; 173():217-225. PubMed ID: 30296646
[TBL] [Abstract][Full Text] [Related]
4. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation.
Chan J; Maghraby GM; Craig JP; Alany RG
Int J Pharm; 2007 Jan; 328(1):65-71. PubMed ID: 17092668
[TBL] [Abstract][Full Text] [Related]
5. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition.
El Maghraby GM
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):595-600. PubMed ID: 19892531
[TBL] [Abstract][Full Text] [Related]
6. Development of water-in-oil microemulsions with the potential of prolonged release for oral delivery of L-glutathione.
Wen J; Du Y; Li D; Alany R
Pharm Dev Technol; 2013; 18(6):1424-9. PubMed ID: 23742726
[TBL] [Abstract][Full Text] [Related]
7. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention.
Alany RG; Rades T; Nicoll J; Tucker IG; Davies NM
J Control Release; 2006 Mar; 111(1-2):145-52. PubMed ID: 16426694
[TBL] [Abstract][Full Text] [Related]
8. Investigation of self-microemulsifying and microemulsion systems for protection of prednisolone from gamma radiation.
El Maghraby GM; Bosela AA
Pharm Dev Technol; 2011 Jun; 16(3):237-42. PubMed ID: 20148711
[TBL] [Abstract][Full Text] [Related]
9. Phase transition of a microemulsion upon addition of cyclodextrin - applications in drug delivery.
Thakur SS; Solloway J; Stikkelman A; Seyfoddin A; Rupenthal ID
Pharm Dev Technol; 2018 Feb; 23(2):167-175. PubMed ID: 28828910
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
11. Formulation and characterization of liquid crystal systems containing azelaic acid for topical delivery.
Aytekin M; Gursoy RN; Ide S; Soylu EH; Hekimoglu S
Drug Dev Ind Pharm; 2013 Feb; 39(2):228-39. PubMed ID: 22480294
[TBL] [Abstract][Full Text] [Related]
12. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
[TBL] [Abstract][Full Text] [Related]
13. An environmentally safe larvicide against Aedes aegypti based on in situ gelling nanostructured surfactant systems containing an essential oil.
Ferreira SG; Conceição VS; Gouveia NS; Santos GS; Santos RL; Lira AA; Cavalcanti SC; Sarmento VH; Nunes RS
J Colloid Interface Sci; 2015 Oct; 456():190-6. PubMed ID: 26125515
[TBL] [Abstract][Full Text] [Related]
14. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
15. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
Bharti SK; Kesavan K
Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
[TBL] [Abstract][Full Text] [Related]
16. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content.
Montenegro L; Carbone C; Condorelli G; Drago R; Puglisi G
Drug Dev Ind Pharm; 2006 Jun; 32(5):539-48. PubMed ID: 16720409
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components.
Yotsawimonwat S; Okonoki S; Krauel K; Sirithunyalug J; Sirithunyalug B; Rades T
Pharmazie; 2006 Nov; 61(11):920-6. PubMed ID: 17152984
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate.
Báez-Santos YM; Otte A; Mun EA; Soh BK; Song CG; Lee YN; Park K
Int J Pharm; 2016 Nov; 514(1):314-321. PubMed ID: 27863678
[TBL] [Abstract][Full Text] [Related]
19. The Development and Evaluation of Phase Transition Microemulsion for Ocular Delivery of Acetazolamide for Glaucoma Treatment.
Abd El Wahab LM; Essa EA; El Maghraby GM; Arafa MF
AAPS PharmSciTech; 2022 Nov; 24(1):1. PubMed ID: 36417044
[TBL] [Abstract][Full Text] [Related]
20. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems.
Alany RG; Tucker IG; Davies NM; Rades T
Drug Dev Ind Pharm; 2001 Jan; 27(1):31-8. PubMed ID: 11247533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
